HeartSciences Inc. (NasdaqCM: HSCS)
Health Care · Health Care Equipment & Supplies · US
$3.21
+0.94% today · -11.2% 1Y
HeartSciences Inc. (NasdaqCM: HSCS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $15.26M and employs 14 people.
Over the last twelve months the share price has lost 11.2%, trading between 1.63 and 5.25.
Tweenvest scores HeartSciences Inc. across four factors: quality 9/100, value 60/100, growth 0/100. Its strongest factor is value.
HSCS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.26M
- Revenue (TTM)
- $4.52K
- P/E
- —
- EPS
- -3.19
- Dividend yield
- —
- Beta (5Y)
- 1.78
- 52-week high
- $5.25
- 52-week low
- $1.63
- Avg volume (3M)
- —
- Shares outstanding
- 4.80M
- Employees
- 14
- Next earnings
- —
About HeartSciences Inc.
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.
- ISIN
- US42254E3027
- Founded
- 2007
- Listed since
- Jun 16, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| IRIDEX CorporationNasdaqCM: IRIX | $15.63M | $0.94 | +5.61% |
| Avience Biomedicals LimitedNSEI: AVIENCE | $15.56M | Rs274.50 | -15.21% |
| ImpediMed LimitedASX: IPD | $15.33M | AU$0.01 | +20.00% |
| Pulsenmore Ltd.TASE: PLSM | $15.32M | ₪5.82 | -15.45% |
| Scandinavian Real Heart AB (Publ)OM: HEART | $15.08M | Skr17.85 | +0.56% |
| Etropal ADBUL: ETR | $14.89M | €2.62 | -1.50% |
| IBI Silver Castle LtdTASE: IBIS | $14.89M | ₪24.99 | -20.54% |
| Neurotech International LimitedASX: NTI | $14.66M | AU$0.01 | -10.34% |
Figures last refreshed Oct 11, 2026.